[HBsAg loss with Pegylated-interferon alfa-2a in hepatitis B patients with partial response to nucleos(t)-ide analog: new switch study].
Hu, P
[HBsAg loss with Pegylated-interferon alfa-2a in hepatitis B patients with partial response to nucleos(t)-ide analog: new switch study]. [electronic resource] - Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology Oct 2018 - 756-764 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
1007-3418
10.3760/cma.j.issn.1007-3418.2018.10.005 doi
Antiviral Agents--therapeutic use
DNA, Viral
Hepatitis B Surface Antigens--immunology
Hepatitis B e Antigens--immunology
Hepatitis B, Chronic--drug therapy
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Polyethylene Glycols--therapeutic use
Recombinant Proteins
Treatment Outcome
[HBsAg loss with Pegylated-interferon alfa-2a in hepatitis B patients with partial response to nucleos(t)-ide analog: new switch study]. [electronic resource] - Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology Oct 2018 - 756-764 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
1007-3418
10.3760/cma.j.issn.1007-3418.2018.10.005 doi
Antiviral Agents--therapeutic use
DNA, Viral
Hepatitis B Surface Antigens--immunology
Hepatitis B e Antigens--immunology
Hepatitis B, Chronic--drug therapy
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Polyethylene Glycols--therapeutic use
Recombinant Proteins
Treatment Outcome